StopDown
Zenex Animal Health logo
Acquisition · 27 February 2026Zenex Animal HealthZenex Animal Healthzenexah.com ↗
Acquisition

Zenex buys majority stake in VievePharm

By · Editor ·

Ahmedabad
  • Zenex took a controlling share in VievePharm, a Dutch maker of natural animal nutrition products, for an undisclosed price
  • The deal gives the Indian firm a factory and sales base in Western Europe, where rules on antibiotics are tightening
  • VievePharm's bolus (large slow-release tablet) know-how for minerals, vitamins and udder health will join Zenex's global range

What happened

  • Zenex Animal Health India bought a majority stake in VievePharm of the Netherlands.
  • VievePharm makes plant-based feed formulations for livestock, horses and pets.
  • It is based in Enter, in the Netherlands.
  • The EU wants veterinary antibiotic sales cut by 50% by 2030 from 2018 levels.

The numbers around it

Zenex Animal Health has 1 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
6 December 2021Growth equity$52.5 millionUndefined

Read it as a card in the app

Terms in this story

  • Majority stake acquisition: A majority stake deal is an acquisition in which the buyer takes more than half of a company, often 51%, and agrees on how the remaining shares may be bought later. It gives the buyer control now, keeps the founders invested, and spreads the price over time.

Everything on Zenex Animal Health → · All startup news on 27 February 2026 →

Is this Zenex Animal Health? Get your “Featured on StopDown” badge →